Squamous Cell Carcinoma of the Head and Neck Treatment Market to 2025: Bayer, Fresenius Kabi, Teva Pharmaceuticals, AbbVie, Astellas Pharma, AstraZeneca

The increase in the geriatric population all over the world demands for the increased funding in oncology domain. The Global Squamous Cell Carcinoma of the head and neck treatment market is set to register a CAGR of 9%, rising from its initial estimated value of USD 0.81 billion in 2017, to an estimated value of USD 1.61 billion in 2025.

Press Release

Global Squamous Cell Carcinoma of the Head and Neck Treatment Market, By Type (Salivary Gland, Oral & Oropharyngeal, Nasal Cavity & Paranasal Sinus, Nasopharyngeal, Laryngeal & Hypo pharyngeal), Diagnosis (Bioscopy screening tests, Blood tests, Dental diagnosis, Imaging, Endoscopy), Treatment (Radiation, Surgery, Chemotherapy, Immunotherapy), Therapeutic Class (PD Inhibitors, EGFR Inhibitors, Microtubule Inhibitors, Mitotic Inhibitors), End-User (Hospitals, Specialty clinics, Ambulatory surgical centers), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Forecast to 2025

Get Free Sample Copy of this Report @

Key Market Competitors:

  • Sanofi,
  • Pfizer Inc.,
  • Eli Lilly and Company,
  • Bristol-Myers Squibb Company,
  • Merck KGaA,
  • Bayer AG,
  • Fresenius Kabi AG,
  • Teva Pharmaceutical Industries Ltd.,
  • AbbVie Inc.,
  • Acceleron Pharma Inc.,
  • Astellas Pharma Inc.,
  • AstraZeneca,
  • Sumitomo Dainippon Pharma Co. Ltd.,
  • Siemens Healthcare GmbH,
  • Varian Medical Systems Inc.,
  • Advaxis Inc.,
  • Amgen Inc.,
  • Azanta Danmark A/S,
  • Boehringer Ingelheim International GmbH,
  • Curis Inc.,
  • Hoffmann-La Roche Ltd,
  • GlaxoSmithKline plc.

Competitive Analysis: Global Squamous Cell Carcinoma of the Head and Neck Treatment Market

The Global Squamous Cell Carcinoma of the Head and Neck Treatment Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of squamous cell carcinoma of the head and neck treatment market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Market Drivers:

  • High number of cases of the specific type of cancer has caused a surge in the industry
  • Developing economies and infrastructure have resulted in better research and development for the market causing the market to grow significantly

Market Restraints:

  • High treatment costs, even though the cancer is diagnosed early is halting the market growth
  • Increasing rate of late stage clinical trials is one of the major factors disrupting the market growth


By Type

  • Salivary Gland
  • Oral & Oropharyngeal
  • Nasal Cavity & Paranasal Sinus
  • Nasopharyngeal
  • Laryngeal & Hypo pharyngeal

By Diagnosis

  • Bioscopy screening tests
  • Incisional biopsy
  • Fine needle aspiration
  • Human papillomavirus testing
  • Blood tests
  • Total cell count
  • Liver function
  • Epstein-Barr Virus antibody measurement
  • Dental diagnosis
  • Fluorescence visualization
  • Toluidine blue dye-based
  • Acetic acid rinse
  • Brush biopsy
  • Imaging
  • CT scan
  • MRI
  • X-Ray
  • Barium swallow
  • Endoscopy
  • Pharyngoscopy
  • Laryngoscopy
  • Others

By Treatment

  • Radiation
  • External beam
  • Internal
  • Surgery
  • Chemotherapy
  • Immunotherapy

By Therapeutic Class

  • PD Inhibitors
  • EGFR Inhibitors
  • Microtubule Inhibitors
  • Mitotic Inhibitors

By End-User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

Inquiry Before Buying @

Frequently Asked Questions:

  • What will the market size be in 2025?
  • What are the key factors driving the global market?
  • What are the challenges to market growth?
  • Who are the key players in the market?
  • What are the market opportunities and threats faced by the key players?
  • What will be the growth rate in 2025?
  • Which strategies are used by top players in the Global Squamous Cell Carcinoma of the Head and Neck Treatment Market?

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]


Related Articles